Pulmonary diseases such as lung cancer, asthma and tuberculosis have remained one of
the common challenges globally. Polymeric micelles (PMs) have emerged as an effective …

The use of trans-nasal pulmonary aerosol delivery via high-flow nasal cannula (HFNC) has
expanded in recent years. However, various factors influencing aerosol delivery in this …

The biomedical use of nanoparticles (NPs) has been the focus of intense research for over a
decade. As most NPs are explored as carriers to alter the biodistribution, pharmacokinetics …

Background High flow nasal cannula (HFNC) is a respiratory device increasingly used to
treat asthma. Recent mechanistic studies have shown that nebulized medications may have …

Pulmonary drug delivery is complex due to several challenges including disease-, patient-,
and clinicians-related factors. Although many inhaled medications are available in aerosol …

BACKGROUND: Nebulizers are commonly used in emergency departments to deliver
bronchodilators to children with asthma exacerbations. However, no clinical study …

High‐flow nasal cannula (HFNC) oxygen therapy, which is important in noninvasive
respiratory support, is increasingly being used in critically ill neonates with respiratory failure …

Although using aerosolized medications is a mainstay of treatment in children with asthma
and other respiratory diseases, there are many issues in terms of device and interface …

Successful aerosol therapy in mechanically ventilated patients depends on multiple factors.
Among these, position of nebulizer in ventilator circuit and humidification of inhaled gases …

The development of mesh nebulizer technology has expanded the ability to deliver medical
aerosols to infants and small children via nasal cannula and prongs. Mesh nebulizers do not …